AdvaMed Looks To Leverage U.S. Regs For Global Convergence
This article was originally published in The Gray Sheet
Executive Summary
The trade group, under its new board chairman José Almeida, plans to push for the relatively new U.S. unique device identifier and Sunshine Act regulations to be the basis of globally harmonized mandates.
You may also be interested in...
U.S., China Reach ‘Understanding’ To Eliminate Device Tariffs
After two years of back and forth, the two countries are close to a deal that would expand the World Trade Organization’s Information Technology Agreement and slash tariffs on high-tech products including medical devices.
AdvaMed Solidifies Its Presence In China
The association expects China's official recognition of its Shanghai office will make it easier to establish partnerships with Chinese authorities and will provide its members with more opportunities to engage on policy issues in the country.
AdvaMed Solidifies Its Presence In China
The association expects China's official recognition of its Shanghai office will make it easier to establish partnerships with Chinese authorities and will provide its members with more opportunities to engage on policy issues in the country.